Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st April, 2020 till 48 hours after the declaration of audited financial results for the quarter / year ending 31st March, 2020. The date of the Board Meeting to consider the audited financial results for the quarter / financial year ending 31st March, 2020, shall be intimated separately. This is for your information and record.
30-03-2020
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

 We wish to inform you that Mr. T. S. Narayanasami (DIN : 01786981) - Independent Director has resigned from the Board of Directors the Company, owing to certain health problems. Further, Mr. T. S. Narayanasami has confirmed that there are no other material reasons for his resignation other than as mentioned above. A copy of the resignation letter dated 29th February, 2020, received from Mr. T. S. Narayanasami is enclosed. This is for your information and records.
03-03-2020
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2019

 Dear Sir, The Board of Directors of the Company, at their meeting held on 3rd February, 2020, have approved the un-audited financial results for the quarter and nine months ended 31st December, 2019. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2019, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 2.30 p.m. and ended at 4.15 p.m. This is for your information and record.
03-02-2020
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2019

 Dear Sir, The Board of Directors of the Company, at their meeting held on 3rd February, 2020, have approved the un-audited financial results for the quarter and nine months ended 31st December, 2019. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2019, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 2.30 p.m. and ended at 4.15 p.m. This is for your information and record.
03-02-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the provisions of Regulation 39 of the the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a statement of Duplicate Share Certificates issued by the Company in respect of Share Certificates reported to be lost by the shareholder. This is for your information and record.
14-01-2020
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Shareholding for the Period Ended December 31, 2019

 Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
13-01-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that the Company has followed adequate procedure for transfer/dematerialisation of shares and has defaced and cancelled all the certificates for dematerialised shares for the quarter ended 31st December, 2019. This is for your information and record.
13-01-2020
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2019

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Monday, 3rd February, 2020, to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2019. This is for your information and record.
10-01-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended December 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 037352 Name of the Signatory :- AJAY KUMAR SINGHALDesignation :- Company Secretary and Compliance Officer
07-01-2020
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Closure of Trading Window

 Dear Sir, Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st January, 2020 till 48 hours after the declaration of financial results for the quarter ending 31st December, 2019. This is for your information and record. Thanking You, Sincerely Yours, A.K.SINGHAL
23-12-2019
Next Page
Close

Let's Open Free Demat Account